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Abstract
Background: The inappropriate use of antibiotics in hospitals increases resistance, morbidity, and mortality. Little is
currently known about appropriate antibiotic use among hospitals in Lahore, the capital city of Pakistan.
Methods: Longitudinal surveillance was conducted over a period of 2 months among hospitals in Lahore, Pakistan.
Antibiotic treatment was considered inappropriate on the basis of a wrong dosage regimen, wrong indication, or
both based on the British National Formulary.
Results: A total of 2022 antibiotics were given to 1185 patients. Out of the total prescribed, approximately two-
thirds of the study population (70.3%) had at least one inappropriate antimicrobial. Overall, 27.2% of patients had
respiratory tract infections, and out of these, 62.8% were considered as having inappropriate therapy.
Cephalosporins were extensively prescribed among patients, and in many cases, this was inappropriate (67.2%).
Penicillins were given to 283 patients, out of which 201 (71.0%) were prescribed for either the wrong indication or
dosage or both. Significant variations were also observed regarding inappropriate prescribing for several
antimicrobials including the carbapenems (70.9%), aminoglycosides (35.8%), fluoroquinolones (64.2%), macrolides
(74.6%) and other antibacterials (73.1%).
Conclusion: Educational interventions, institutional guidelines, and antimicrobial stewardship programs need to be
developed to enhance future appropriate antimicrobial use in hospitals in Pakistan. Policies by healthcare and
Government officials are also needed to minimize inappropriate antibiotic use.
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Background
The role of antibiotics in successfully treating infectious
diseases cannot be denied. However, inappropriate anti-
biotic use poses a major challenge to public health in
terms of increasing antimicrobial resistance (AMR) with
its associated impact on morbidity, mortality, and costs
as well as increasing adverse effects [1]. This has resulted
in a number of activities globally, regionally, and nation-
ally to reduce rising rates of AMR [2].
Whilst antibiotics are principally prescribed in ambu-
latory care [3], antibiotics are still frequently prescribed
in hospitals. The Centers of Disease Control (CDC) in
the US reported that 55.7% of patients from 323 hospital
settings were given antibiotics during their hospital stay
[4]. There is also high use of antibiotics among hospital
patients in low and middle-income countries (LMICs),
enhanced in some countries by high rates of HIV, TB,
and malaria among in-patients [5–7]. However, there are
concerns about the extent of inappropriate prescribing
of antibiotics in hospitals [8]. According to a hospital
survey in the US, 576 out of 1941 antibiotic therapy days
were not essential due to the unnecessary length of pre-
scribing, use of antibiotics for non-bacterial purposes
and the treatment of colonizing agents [9]. In Romania,
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49.2% prescriptions for antibiotics in an academic hos-
pital were inappropriate on the basis of incorrect doses,
duration and wrong indications [10]. Concerns with
inappropriate prescribing of antibiotics in hospitals are
enhanced by incentives to physicians, limited physician
knowledge regarding antibiotics, and pharmaceutical com-
pany activities in some countries [11, 12].
In LMICs, physicians are particularly challenged with
antimicrobial prescribing due to a lack of diagnostic
facilities and poor level of healthcare systems in a num-
ber of countries as well as a lack of antimicrobial
stewardship programs [13, 14]. As a result, high rates
of antimicrobial resistance have been seen in LMICs
[1, 2]. In a study among private hospitals in Lahore,
Pakistan, the authors found that out of 93 Escherichia coli
isolates, 82% were resistant to beta-lactam antibiotics with
many resistant to fluoroquinolones and trimethoprim-
sulfamethoxazole – attributable to antibiotic overuse [15].
However concerns with antimicrobial prescribing in
LMICs are not universal with 62% of prescriptions for an-
tibiotics in Namibia complying with national guidelines,
although below the target of 95%, and ceftriaxone was ap-
propriately prescribed in hospitals in Ghana [16, 17].
However, the frequent and needless use of antibiotics
has increased AMR rates in Pakistan [18]. There have
been published studies documenting high inappropriate
use of antibiotics in ambulatory care in Pakistan [19].
There have also been a limited number of studies asses-
sing antibiotic use in hospitals in Pakistan [6, 20]. How-
ever, we are not aware of any studies that have fully
evaluated the appropriateness of antimicrobial prescrib-
ing among hospitals in the capital city of Pakistan to
provide guidance to all key stakeholder groups. Conse-
quently, we sought to address this.
Methods
Study design and settings
We conducted a longitudinal observational study over 2
months between March and April 2017 among two pri-
vate hospitals and two public sector hospitals in Lahore,
Pakistan, the capital city of Pakistan. This reflects the
availability of both private and public sector hospitals in
Pakistan. We believed that if we saw major issues re-
garding antimicrobial prescribing among hospitals in the
capital city, Lahore, this would be reflected in hospitals
throughout Pakistan. The participation of hospitals was
voluntary. Antibiotics were prescribed in each hospital
by the physicians in charge of the patients’ care, based
on their own decision, or based on recommendations of
the consultant, with currently no hospital or national
guidelines to guide prescribing. The diagnosis was based
on clinical judgement as typically culture and sensitivity
testing (CST) is not undertaken in hospitals in Pakistan
unless patients are in a critical condition in view of
financial constraints. Patients undergoing treatment with
one or more antibiotics either for a perceived clinical in-
fection or surgical prophylaxis were included in the study.
We assessed the patients who were hospitalized in pul-
monology, gastroenterology, nephrology, orthopedic, and
general surgical/medical wards. We excluded those wards
where antimicrobial prescribing patterns were seen as
same in all patients, e.g., all patients were given ceftriaxone
and metronidazole as prophylaxis in gynecological and ob-
stetric wards. Patient receiving antimicrobials for medical
prophylaxis were also not included because the indication
was not clear. We also excluded all those wards where
systemic antimicrobial use was perceived to be very low
such as eye wards and Ear Nose and Throat (ENT) wards.
Data collection
Patients were categorized according to International Clas-
sification of Diseases (ICD) as being treated for a site-
specific infection such as a respiratory tract infection, in-
cluding lower respiratory tract infections such as pneumo-
nia, tuberculosis, and exacerbations of chronic obstructive
pulmonary disease; a urinary tract infection including
cystitis and pyelonephritis; a skin and soft tissue infection
including bursitis, wound infection and cellulitis; or a
bloodstream infection.
Experienced clinical research coordinators were trained
to collect data prior to initiating the survey. Hospital phar-
macists coordinated the data collection in each ward, while
physicians and nurses also helped with data collection. Data
were collected from progress notes, observation charts,
pathology and microbiology results, and prescription sheets.
The use of antibiotics was considered as surgical prophy-
laxis if mentioned in preoperative assessment documents
and postoperative if prescribed after surgery. With regards
to current antibiotic use, all antibiotics were documented
using the ATC classification [7]. Data collection included
details of the antibiotic therapy regimen including the start
date, dose, route of administration, and the indication for
antibiotic therapy. The results of radiological, microbio-
logical, and pathological investigations available at the time
of the data collection were also studied to help assess the
appropriateness of therapy. The privacy of patients was en-
sured by decoding all data. No patient was interviewed so
no patient consent was needed for the study.
Appropriateness of antibiotics
Institutional guidelines on antibiotic use had not been de-
veloped in any surveyed hospital despite Lahore being the
capital city. In addition, there are no national guidelines
currently available in Pakistan. Furthermore, there is also
no currently established mechanism to implement any
guidelines once available within hospitals in Pakistan, such
as a Drugs and Therapeutic Committee, antibiotic guide-
line groups, or antibiotic stewardship groups.
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Consequently, antibiotic prescribing guidelines from the
British National Formulary were used as the standard to
evaluate the appropriateness of prescribing antibiotics [21].
The British National Formulary (BNF) was selected over
other possible prescribing guidance references because it is
designed for quick reference and is convenient and easy to
use [5]. It is also presently available in Pakistan for free via
the Pakistan Pharmacist Association. In addition, it is also
readily available online, and as paper copies and on mobile
applications, and used as a reference in other LMICs [5].
To check antibiotic appropriateness, antibiotic selection,
dosage form, dose, frequency, duration, contraindication,
hypersensitivity, and antibiotic susceptibility reports were
considered against BNF guidance. Antibiotic treatment
was considered inappropriate on the basis of the wrong
dosage regimen (dosage form, dose, frequency, or duration)
or the wrong indication (selection based on indication,
spectrum, contraindication, or hypersensitivity) or both.
Data were analyzed using Statistical Program for Social
Sciences (SPSS version 20). Simple descriptive statistics
were applied to analyze patterns of infection, antibiotic
use and the appropriateness of antibiotic prescribing
among hospitalized patients. We did not break the
figures down into public and private hospitals because
we wanted a general picture across both sectors before
looking further at specific hospital sites and categories.
Ethics approval and consent to participate
The study was approved and registered from the Ethics
committee on human research, University College of
Pharmacy, University of the Punjab, Lahore, Pakistan,
under the registration number (HEC/1000/PUCP/1925I).
Since the study did not contain any individual person’s
data in any form (including any individual details, images
or videos), the ethics committee has granted an exemption
from consent to be issued before accessing their files. The
head of departments of various wards and their staff phy-
sicians and nurses were informed about the study and
they allowed the principal investigators (ZS, UA) to con-
duct the study in the respective wards.
Results
The demographic and clinical properties of the study popu-
lation are summarized in Table 1. A total of 1185 patients
were included with almost an equal number of male (n=
595) and female (n = 590) patients. A total of 2022 antibi-
otics were given for 1185 patients. Patients receiving single
antibiotic treatment (43.4%) or combination therapy (56.6%)
were studied for the appropriateness of their antibiotic treat-
ment. Data collectors gathered the data from a number of
wards in the hospitals, including gastroenterology (25.8%),
pulmonology (23.2%) and other specialized departments as
listed in Table 1.
Out of total of 1185 patients on antimicrobial therapy,
only 29.7% received appropriate treatment according to
the BNF (Table 1). Whereas, approximately two-thirds of
the study population (70.3%) had at least one inappropri-
ate antimicrobial prescribed. The highest level of inappro-
priate antibiotic use (78.5%) was seen in patients with skin
and soft tissue infections (Table 2). Patients with respira-
tory tract infections were considered as having inappropri-
ate therapy on 62.8% of occasions. The lowest level of
inappropriate antimicrobial prescribing was seen among
patients with bloodstream infections where only 41.2%
were seen as inappropriate. Pre-operative prophylaxis
was given in 12% of patients with 67.6% having an in-
appropriate selection.
Table 3 depicts the antimicrobials that were prescribed
to hospitalized patients. Cephalosporins were prescribed
Table 1 Demographic & clinical characteristics (n = 1185)
Parameters Frequency (N) Percentage (%)
Hospital
Public sector 636 53.7
Private sector 549 46.3
Gender
Male 595 50.2
Female 590 49.8
Type of therapy
Single 514 43.4
Combination 671 56.6
Wards
Gastroenterology ward 306 25.8
Pulmonology ward 279 23.5
Nephrology ward 272 22.9
General ward 174 14.8
Orthopedic ward 154 12.9
Appropriateness of therapy
Appropriate 353 29.7
Inappropriate 832 70.3
n = Total No. of patients involved in this study
Table 2 Indication and inappropriateness of antibiotic use
among patients involved in study (n = 1185)
Indication Patient receiving
antibiotics
Inappropriate
N (%)
Frequency (N) Percent (%)
Skin and soft tissue infection 363 30.7 285 (78.5)
Respiratory tract infection 323 27.2 203 (62.8)
Urinary tract infection 183 15.4 138 (75.4)
Gastrointestinal infection 140 11.8 96 (68.6)
Pre-operative Prophylaxis 142 12.0 96 (67.6)
Blood stream infection 34 3.0 14 (41.2)
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most frequently (46.1%), out of which 3rd generation
cephalosporins, e.g., ceftriaxone, were the most prescribed
(78.1%). The second most commonly prescribed antimi-
crobials were the aminoglycosides (15.6%) followed by the
penicillins (14.0%) and fluoroquinolones (9.5%). Then the
frequency of antibiotics use was analyzed at ATC level 5,
as shown in Table 3. The five most commonly used antibi-
otics among the hospitalized patients included ceftriaxone
(21.0%) followed by amikacin (15.2%), cefoperazone plus
sulbactam (11.4%), ciprofloxacin (6.4%) and metronidazole
(5.9%). Among the penicillins, amoxicillin plus clavulanic
acid was the most prescribed (5.6% of antibiotics) while
clarithromycin was the most prescribed macrolide (2.4%
of all antibiotics).
Table 4 was built on Tables 1 and 2 by looking further
at inappropriate indications or dosage or both of all antibi-
otics prescribed. Out of the total prescribed, 1283 (63.5%)
antibiotic prescriptions had either an inappropriate indica-
tion or dosage or both. Cephalosporins were extensively
prescribed among patients (Table 3), and in many cases,
this was inappropriate (67.2%). Most of the first-generation
cephalosporins (80.7%) were inappropriately prescribed
mainly because of inappropriate dosages. Penicillins were
Table 3 Antibiotics prescribed to hospitalized patients (n = 2022)
Antibiotic (ATC codes) Frequency
prescribed (N)
Percentage (%)
Penicillins 283 14
Narrow and broad spectrum 120 42.4
Ampicillin (J01CA01) 14 0.7
Amoxicillin (J01CA04) 27 1.3
Penicillin v (J01 CE08) 79 3.9
Combination with β-
lactamase inhibitor
163 57.6
Amoxicillin and clavulanic
acid (J01CR02)
114 5.6
Piperacillin + tazobactam
(J01CR05)
49 2.4
Cephalosporins 933 46.1
1st generation 114 12.2
Cephalexin (J01DB01) 31 0.2
Cefazolin (J01DB04) 86 4.3
Cephradine (J01DB09) 25 1.3
2nd generation 83 8.9
Cefuroxime (J01 DC02) 72 3.6
Cefaclor (J01 DC04) 11 0.5
3rd generation 729 78.1
Cefotaxime (J01DD01) 23 1.4
Ceftazidime (J01DD02) 20 0.9
Ceftriaxone (J01DD04) 423 21
Cefixime (J01DD08) 32 1.6
Cefoperazone and
salbactum (J01DD62)
231 11.4
4th generation 7 0.80
Cefepime (J01DE01) 7 0.3
Carbapenems 31 1.5
Imipenem (J01DH51) 9 0.4
Meropenem (J01DH02) 22 1
Macrolides 59 2.9
Erythromycin (J01FA01) 4 0.2
Clarithromycin (J01FA09) 48 2.4
Azithromycin (J01FA10) 7 0.3
Aminoglycosides 315 15.6
Gentamicin (J01GB03) 8 0.4
Amikacin (J01GB06) 307 15.2
Fluoroquinolones 193 9.5
Ciprofloxacin (J01MA02) 130 6.4
Levofloxacin (J01MA12) 17 0.8
Moxifloxacin (J01MA14) 41 2
Ofloxacin (J01MA01) 3 0.1
Norfloxacin (J01MA06) 2 0.09
Table 3 Antibiotics prescribed to hospitalized patients (n = 2022)
(Continued)
Antibiotic (ATC codes) Frequency
prescribed (N)
Percentage (%)
Others Antibacterials 208 10.4
Vancomycin (J01XA01) 80 4.0
Metronidazole (J01XD01) 119 5.9
Linezolid (J01XX08) 9 0.5
Table 4 Inappropriate antibiotic Usage (n = 2022)
Antibiotics Inappropriate
indication
N (%)
Inappropriate
dosage
N (%)
Inappropriate
treatment
N (%)
Penicillins 173 (61.1) 140 (49.5) 201 (71.0)
Narrow/broad spectrum 81 (67.5) 92 (76.7) 102 (85.0)
With β-lactamase
inhibitor
92 (56.4) 48 (29.5) 99 (60.7)
Cephalosporins 470 (50.4) 418 (44.8) 627 (67.2)
1st generation 37 (32.5) 72 (86.7) 92 (80.7)
2nd generation 32 (38.5) 49 (59.1) 66 (79.5)
3rd generation 395 (54.2) 293 (40.2) 463 (63.5)
4th generation 6 (85.7) 4 (57.1) 6 (85.7)
Carbapenems 20 (76.6) 18 (58.1) 22 (70.9)
Macrolides 37 (62.7) 29 (49.2) 44 (74.6)
Aminoglycosides 67 (21.2) 84 (26.6) 113 (35.8)
Fluoroquinolones 71 (36.8) 108 (55.9) 124 (64.2)
Others Antibacterial 67 (32.2) 133 (63.9) 152 (73.1)
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given to 283 patients, out of which 201 (71.0%) were pre-
scribed either the wrong indication or dosage or both.
There was the least inappropriate use of aminoglycosides
(35.8%) (Table 4).
Discussion
The appropriate use of antibiotics plays an important
role in reducing the burden of AMR and establishing a
cost-effective healthcare system. Disappointingly, 70.3%
of patients in our study received inappropriate anti-
microbial therapy, much higher that reported in previous
studies conducted in Australia and Turkey [22, 23]. In
addition, in Namibia where only 38% of antibiotic pre-
scriptions did not comply with current national guide-
lines [16] and in Ghana where the appropriateness of
the indication for ceftriaxone in a leading hospital was
86% [17]. Surprisingly, inappropriate prescribing of anti-
biotics for bold stream infections was found to be only
41.2% in this study. This may be due to blood stream in-
fections being seen as more life threatening compared to
other types of infection and consequently more attention
is paid to them by senior clinicians. This may need fur-
ther investigation as we cannot say this with certainty.
In our study, we found that third-generation cephalo-
sporins were the most frequently prescribed antimicro-
bial, and more than half (67.2%) were prescribed
inappropriately. However, this is similar to studies in
South Africa where poor compliance to indications, ad-
ministration, and current guidelines was seen for pre-
operative prophylaxis in children [24], and in Botswana
and Kenya where there was a high rate of inappropriate
antimicrobial prescribing post-operatively to help pre-
vent surgical site infections [25, 26]. A study in the US
also reported that an incorrect diagnosis was the main
reason for inappropriate antimicrobial use in 309 out of
500 patients [27]. Our findings are also similar to other
studies published from Pakistan, which showed high in-
appropriate antibiotic use. In these studies, 88 to 97.6%
of antibiotics were prescribed to the patients without a
request for a culture test [20, 28, 29]. A cross-sectional
study on physician prescribing practices in Pakistan also
reported that more than 70% of antibiotics were pre-
scribed by the doctors on patient demand, exacerbated
by the fact that the majority of the physicians in the
study had not received any kind of training on rational
antibiotic prescribing practices [30].
Despite the efforts of the WHO towards developing
and implementing strategies to enhance appropriate
antimicrobial use, good antimicrobial prescribing prac-
tices are still not followed in a number of LMICs [31,
32]. The WHO has also emphasized antimicrobial stew-
ardship programs (ASP) including patient and prescriber
education, delayed prescribing, guideline implementa-
tion, laboratory testing, and decision support systems,
although ASPs can be a particular challenge in LMICs
enhanced by manpower issues and available funding
[14]. However, this is starting to be addressed [33].
Healthcare providers should also carefully evaluate
medication appropriateness and should know about the
benefits and risks before prescribing antibiotics to pa-
tients [34]. Pertinent knowledge gaps among prescribers
need to be addressed with updated prescribing guide-
lines and continual medical education to minimize the
unnecessary use of antibiotics in hospital settings [16,
35]. Research programs, educational sessions by health-
care experts in collaboration with Government officials
and professional training can also enhance appropriate
prescribing habits among healthcare practitioners along-
side the instigation of ASPs among hospitals in Pakistan
[36]. Appropriate documentation of medication records
among patients receiving antibiotics can also help reduce
the over the use of antibiotics by providing a timely re-
minder of current usage patterns and their rationale and
avoiding issues such as missed doses [7, 37]. There
should also be a key focus on diagnostic facilities, audits
on drug dispensing and prescribing as well as a liaison
among academia and healthcare professionals to im-
prove future care based on rational decision making.
Education among medical and pharmacy students
should also focus on applied pharmacology and clinical
pharmacy, including infection and the appropriate use of
antibiotics to address key concerns [11, 19]. The pres-
ence of pharmacists in hospitals can also favourably in-
fluence antimicrobial use in collaboration with other
healthcare practitioners through Pharmacy and Thera-
peutic Committees (PTCs) and helping to develop ASPs
in hospitals where these have not existed before [33].
The presence of infectious disease specialists in hospitals
may also further help to minimize irrational antibiotic
prescribing [38]. Consequently, professional training of
healthcare practitioners, execution of essential medicine
lists, active PTCs and ASPs, as well encouraging adher-
ence to nationally agreed guidelines can all help to re-
duce inappropriate antibiotic use in hospitals [14].
We are aware of a number of limitations with this
study. Firstly, the information collected was dependent
on the knowledge and training of individual data collec-
tors. Whilst each of these data collectors was provided
with detailed information, variability between data col-
lectors could not totally be excluded. Secondly, the ap-
propriateness of antibiotic selection was based on the
assumption that the diagnosis was accurate as CST re-
ports are not in place in most of the hospitals. This is al-
ways a limitation of this type of study in the majority of
LMICs. Thirdly, treatment outcomes were not checked
as our primary focus was the appropriateness of the anti-
biotic used. Fourthly, the educational background of the
doctors and other medical staff was not considered in
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this study, neither was disaggregating the findings from
private from public hospitals, as we wanted to gain base-
line data. Lastly, although this longitudinal survey gave a
detailed view of the appropriateness of antibiotic pre-
scribing in the four hospitals surveyed, which were rep-
resentational of Lahore, we cannot be fully confident
that our findings are replicated throughout Pakistan.
However, despite these limitations, we believe our find-
ings are robust, providing direction to key stakeholders
in Pakistan in the future to improve antibiotic use in
hospitals. This will be followed up.
Conclusion
Inappropriate antimicrobial use was frequently observed
among the studied hospitals in Lahore. More than half of
the patients had inappropriate antimicrobial therapy, and
cephalosporins were frequently prescribed to these pa-
tients. This inappropriate use can be minimized through
educational interventions for healthcare practitioners, in-
stitutional guidelines for appropriate antimicrobial use,
implementation of antimicrobial stewardship programs
and development of strategies by healthcare professionals
and Government officials to combat unnecessary and
overuse of antimicrobials in hospitals. These are consider-
ations for the future and will be followed up in future
research.
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